Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

I don't know how many people of my cohort were listening to Janis Ian alone on headphones in their bedrooms when her album ...

Atomic-scale imperfections in graphene transistors generate unique wireless fingerprints that cannot be copied or predicted, ...

As of Friday, January 02, Marvell Technology, Inc.’s MRVL share price has surged by 5.25%, which has investors questioning if ...

Even if fly-halves are considered to be the brainiest members of any team – a cliché that line-out callers might contest – ...

Our test car was a brand-new Z28 with the familiar port-fuel-injected 5.0-liter V-8 mated to a five-speed manual gear­box.

Researchers from Southeast University have developed a compact, dual-band, dual-polarized phased array for B5G/6G ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

Discover the top 26 Nigerian entertainers to watch in 2026. From Afrobeats stars to Nollywood actors and influencers, see who ...

Corcept receives US FDA Complete Response Letter for relacorilant as a treatment for patients with hypercortisolism: Redwood City, California Saturday, January 3, 2026, 14:00 Hrs ...

ward-winning sports journalist, film-maker, and presenter Donald Oliver died suddenly on Tuesday morning, plunging the local ...

BHVN’s investment case definitely weakened after Opakalim’s Phase 2 MDD miss. This also means they’ll discontinue their ...